|
DYNC1H1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.089600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.217600E-01 |
| Normal-vs-Stage2 |
5.709800E-01 |
| Normal-vs-Stage3 |
4.798000E-01 |
| Normal-vs-Stage4 |
3.717200E-01 |
| Stage1-vs-Stage2 |
4.484400E-01 |
| Stage1-vs-Stage3 |
4.118400E-01 |
| Stage1-vs-Stage4 |
3.084600E-01 |
| Stage2-vs-Stage3 |
2.070000E-01 |
| Stage2-vs-Stage4 |
1.753770E-01 |
| Stage3-vs-Stage4 |
8.212600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.296800E-01 |
| Normal-vs-AfricanAmerican |
3.010400E-01 |
| Normal-vs-Asian |
9.544600E-01 |
| Caucasian-vs-AfricanAmerican |
2.086600E-01 |
| Caucasian-vs-Asian |
7.885800E-01 |
| AfricanAmerican-vs-Asian |
3.317800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.057400E-01 |
| Normal-vs-Female |
9.537000E-01 |
| Male-vs-Female |
1.254830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.202800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.317800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.715200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.235800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.241000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.735370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.284000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.855600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.654800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.126600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.921200E-01 |
| Classical-VS-Follicular |
1.962100E-04 |
| Classical-VS-Other |
6.306300E-02 |
| Classical-VS-Normal |
4.539600E-01 |
| Tall-VS-Follicular |
2.117800E-01 |
| Tall-VS-Other |
1.735410E-01 |
| Tall-VS-Normal |
6.783800E-01 |
| Follicular-VS-Other |
5.643800E-01 |
| Follicular-VS-Normal |
4.728400E-02 |
| Other-VS-Normal |
9.976300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.502600E-01 |
| Normal-vs-N1 |
1.594200E-01 |
| N0-vs-N1 |
2.374400E-01 |
|
|
